Compare STRL & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRL | PEN |
|---|---|---|
| Founded | 1955 | 2004 |
| Country | United States | United States |
| Employees | 1740 | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 12.9B |
| IPO Year | 1996 | 2015 |
| Metric | STRL | PEN |
|---|---|---|
| Price | $447.50 | $329.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 17 |
| Target Price | ★ $443.33 | $357.33 |
| AVG Volume (30 Days) | 427.2K | ★ 543.5K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.42 | ★ 1155.56 |
| EPS | ★ 9.38 | 4.52 |
| Revenue | $957,958,000.00 | ★ $1,403,665,000.00 |
| Revenue This Year | $26.86 | $14.34 |
| Revenue Next Year | $11.52 | $13.71 |
| P/E Ratio | ★ $46.35 | $72.88 |
| Revenue Growth | ★ 38.81 | 17.50 |
| 52 Week Low | $129.21 | $221.26 |
| 52 Week High | $477.03 | $362.41 |
| Indicator | STRL | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 57.17 | 37.63 |
| Support Level | $303.13 | $326.58 |
| Resistance Level | $469.22 | $338.99 |
| Average True Range (ATR) | 25.24 | 2.24 |
| MACD | 1.73 | -0.22 |
| Stochastic Oscillator | 86.36 | 26.14 |
Sterling Infrastructure Inc operates through subsidiaries within three segments: E-Infrastructure, Transportation, and Building Solutions in the United States, mainly across the Southern, Northeastern, Mid-Atlantic, and Rocky Mountain regions and the Pacific Islands. E-Infrastructure Solutions generates maximum revenue and provides site development and mission-critical electrical services for data centers, manufacturing, distribution centers, warehousing, and power generation. Transportation Solutions includes infrastructure and rehabilitation projects for highways, airports, ports, rail, and storm drainage systems. Building Solutions includes residential and commercial concrete foundations, parking structures, plumbing services, and surveys for new single-family residential builds.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.